Skip to main content
Premium Trial:

Request an Annual Quote

GenomeQuest to Award Software to Clinical Labs Transitioning to Next-Gen Sequencing

Premium

GenomeQuest is sponsoring an award program that will provide bioinformatics support to clinical labs that want to transition to next-generation sequencing.

The company said it will award the grants to five labs who are looking to consolidate multiple Sanger-based diagnostic tests into a single NGS-based test.

Labs that are awarded the grants, which the company values at $20,000 each, will receive all the software, annotation data, and compute infrastructure required to process and store patient sequence data, produce tailored diagnostic reports, and perform follow-up research on aggregated results, according to the company.

To qualify for the grant, labs must operate a medical diagnostic lab that is listed under the National Center for Biotechnology Information's GeneTests website and also be committed to transitioning to NGS-based testing.

Applications are due Dec. 1 and the awards will be announced Dec. 15. Further information about the program is available on GenomeQuest's website.

The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.